SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,497 | -1.0% | 1,555 | -6.5% | 0.00% | 0.0% |
| Q2 2023 | $190,447 | +10.4% | 1,663 | +32.8% | 0.00% | 0.0% |
| Q1 2023 | $172,563 | +3.3% | 1,252 | -2.9% | 0.00% | 0.0% |
| Q4 2022 | $167,029 | +14.4% | 1,289 | -2.2% | 0.00% | 0.0% |
| Q3 2022 | $146,000 | +49.0% | 1,318 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $98,000 | -21.0% | 1,314 | -16.9% | 0.00% | 0.0% |
| Q1 2022 | $124,000 | -12.7% | 1,581 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $142,000 | +2.2% | 1,581 | +5.5% | 0.00% | 0.0% |
| Q3 2021 | $139,000 | +11.2% | 1,499 | -7.1% | 0.00% | – |
| Q2 2021 | $125,000 | -0.8% | 1,613 | -4.5% | 0.00% | – |
| Q1 2021 | $126,000 | -60.9% | 1,689 | -10.7% | 0.00% | -100.0% |
| Q4 2020 | $322,000 | +17.9% | 1,891 | -2.9% | 0.00% | 0.0% |
| Q3 2020 | $273,000 | -16.3% | 1,947 | -4.4% | 0.00% | -50.0% |
| Q2 2020 | $326,000 | +107.6% | 2,036 | +26.9% | 0.00% | +100.0% |
| Q1 2020 | $157,000 | -26.6% | 1,605 | -3.0% | 0.00% | 0.0% |
| Q4 2019 | $214,000 | +64.6% | 1,655 | -4.1% | 0.00% | 0.0% |
| Q3 2019 | $130,000 | -50.4% | 1,725 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $262,000 | +41.6% | 1,725 | +11.3% | 0.00% | 0.0% |
| Q1 2019 | $185,000 | +5.7% | 1,550 | -3.4% | 0.00% | 0.0% |
| Q4 2018 | $175,000 | -27.7% | 1,605 | +7.3% | 0.00% | 0.0% |
| Q3 2018 | $242,000 | +22.2% | 1,496 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $198,000 | -93.2% | 1,496 | -96.2% | 0.00% | -90.0% |
| Q1 2018 | $2,894,000 | +26.4% | 39,065 | -5.1% | 0.01% | +25.0% |
| Q4 2017 | $2,290,000 | +27.4% | 41,166 | +3.8% | 0.01% | +33.3% |
| Q3 2017 | $1,798,000 | +65.4% | 39,644 | +23.0% | 0.01% | +50.0% |
| Q2 2017 | $1,087,000 | +20.9% | 32,233 | +6.1% | 0.00% | +33.3% |
| Q1 2017 | $899,000 | +33.4% | 30,370 | +23.6% | 0.00% | 0.0% |
| Q4 2016 | $674,000 | -100.0% | 24,574 | -0.3% | 0.00% | -50.0% |
| Q3 2016 | $1,513,020,000 | +222.5% | 24,638 | +0.2% | 0.01% | +200.0% |
| Q2 2016 | $469,141,000 | -29.7% | 24,601 | -28.0% | 0.00% | -33.3% |
| Q1 2016 | $667,000,000 | -45.0% | 34,154 | +8.7% | 0.00% | -40.0% |
| Q4 2015 | $1,212,000,000 | +130927.0% | 31,421 | +9.0% | 0.01% | +25.0% |
| Q3 2015 | $925,000 | -99.9% | 28,823 | +7.0% | 0.00% | +33.3% |
| Q2 2015 | $819,906,000 | +121.0% | 26,944 | -3.6% | 0.00% | +50.0% |
| Q1 2015 | $371,017,000 | -4.9% | 27,938 | +3.6% | 0.00% | 0.0% |
| Q4 2014 | $390,300,000 | -32.5% | 26,973 | -1.6% | 0.00% | -33.3% |
| Q3 2014 | $578,393,000 | -28.6% | 27,412 | +0.8% | 0.00% | -25.0% |
| Q2 2014 | $810,050,000 | +29.0% | 27,192 | +4.0% | 0.00% | +33.3% |
| Q1 2014 | $628,096,000 | +20.8% | 26,138 | +2.4% | 0.00% | 0.0% |
| Q4 2013 | $519,924,000 | -50.6% | 25,524 | +14.6% | 0.00% | -50.0% |
| Q3 2013 | $1,051,954,000 | +1368.7% | 22,273 | +1082.8% | 0.01% | – |
| Q2 2013 | $71,627,000 | – | 1,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |